Stock PTEO PROTEO, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Proteo, Inc.

Equities

PTEO

US74369R4074

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
U.S. Special Forces launch counter-terrorism drills with African armies
RE
PROTEO INC : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
PROTEO INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
PROTEO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Proteo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020
CI
PROTEO INC : Other Events (form 8-K)
AQ
PROTEO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
Proteo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019
CI
PROTEO INC : Other Events (form 8-K)
AQ
PROTEO INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
Proteo, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
CI
Proteo, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019
CI
Proteo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019
CI
Proteo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018
CI
Proteo, Inc. Announces Management Changes
CI
Proteo, Inc. and Proteo Biotech AG Announces Final Analysis of the Phase II Clinical Study on Elafin in Coronary Artery Bypass Surgery
CI
Proteo Inc : Patient recruitment and treatment in Elafin CABG Phase II clinical trial completed
PU
PROTEO INC : Proteo, Inc. / Proteo Biotech AG: EMPIRE-Study recruits first coronary bypass patients
PU
PROTEO INC : Proteo, Inc./ Proteo Biotech AG: Proteo's Elafin Will Be Tested at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)
BU
PROTEO : Proteo, Inc./Proteo Biotech AG: Clinical Study in Harvard Reveals Elafin Deficiency in Acute Respiratory Distress Syndrome (ARDS)
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PTEO Stock
  4. News Proteo, Inc.